contents.xj-storage.jp/xcontents/05997/02bd6529/7d2e/409f/88bd/b6c5a7ed9180/20240520110953191s.pdf

archives

This URL has 1 public saves. The first save was Jun 28, 2026, 04:00 PM and the latest save was Jun 28, 2026, 04:00 PM.

View recent saves on this domain

Latest saved version

2024年12月期第1四半期決算説明会

This is the newest public snapshot for this URL and the best place to start reviewing the page.

Jun 28, 2026, 04:00 PM

Source URL

https://contents.xj-storage.jp/xcontents/05997/02bd6529/7d2e/409f/88bd/b6c5a7ed9180/20240520110953191s.pdf

About this page

This document is a report on the first quarter financial results for the fiscal year ending December 2024, presented by Masuka, the Chairman and Group CEO, and Takada, the President and Domestic CEO. It discusses the comparison with the previous year's first quarter, addressing the impacts of COVID-19 and issues in the pharmaceutical industry, highlighting a decrease in revenue but an increase in operating profit. The document also covers the status of the U.S. subsidiary Xyvid, as well as the progress in the Event DX, Third Place, and Enterprise DX segments. Notably, the achievements in cost reduction and structural reforms are emphasized, indicating expectations for future growth.

Total saves

1

Latest save

Jun 28, 2026, 04:00 PM

First save

Jun 28, 2026, 04:00 PM

Saved versions

contents.xj-storage.jp/xcontents/05997/02bd6529/7d2e/409f/88bd/b6c5a7ed9180/20240520110953191s.pdf web archives are listed here. You can still review the saved screenshot and HTML even if the original page disappears.